Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure

ConditionAnal Fissure
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAmerican University of Beirut Medical Center

About this trial

No study to date has compared topical DTZ to MEBO ointment in the treatment of anal fissure. Therefore, the present study aims to compare the efficacy and safety of DTZ to MEBO in the treatment of acute anal fissure. The investigators propose to conduct a comparative randomized clinical study. In this study, the investigators will compare patients with acute anal fissure receiving MEBO ointment vs Topical DTZ ointment vs a combination of MEBO and DTZ ointment.

Hypothesis:

MEBO in combination with DTZ is more effective than DTZ or MEBO alone in the treatment of acute anal fissure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects must be 18 years and above.

Subjects with 3 months (90 days) or less history of painful anal fissure (AF), prior to screening, where AF-related pain-associated with, or following, defecation is experienced at least twice a week during the symptomatic phase, with pain scores at an average of ≥ 3 on an 11-point NRS (Numerical Rating Scale, range 0-10 where 0 = no pain and 10 = worst pain imaginable).

Subjects with an average of ≥4 on an 11-point NRS during the screening phase for worst anal pain associated with, or following, defecation for the most recent 3 days on which the subject has defecated.

Subjects with evidence of a radial fissure, with induration at the edges, seen on anal examination.

Disqualifiers

Subjects unwilling to be examined for AF.

Lateral sphincterotomy or anal stretch or other previous surgery involving the anal canal or perianal region (hemorrhoidectomy, anal fistula surgery).

Incision of perianal abcess.

Subjects who have had sub-fissure injection of botulinum toxin within 6 months period prior to screening, or have used glyceryl trinitrate (GTN) ointment for >1 week in the 4 weeks prior to the screening visit.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Diltiazem

    Drug

    DTZ is a calcium channel blocker for the treatment of chronic anal fissure

  • Mebo

    Drug

    Moist exposed burn ointment (MEBO) is a tropical Chinese medicine composed of sesame oil and herbal plants that is clinically used for the treatment of burn wound.

Treatment groups

183 Participants
are divided into 3 treatment groups
Group A: DTZ armExperimental treatment 1 intervention
Group B: MEBO armExperimental treatment 1 intervention
Group C: MEBO and DTZ armExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in Pain Score

Pain is evaluated through the Numerical Rating Scale, range 0-10 where 0 = no pain and 10 = worst pain imaginable

Time frame
Baseline to 1 week from the start date of the study
2

Wound Healing

Wound healing is assessed through physical examination: digital rectal examination is not done in case of painful anal fissure. Assessment for wound healing will be performed by the treating physician of the patient. The patient will be asked to strain to make the anal fissure more visible. If it is difficult to see on physical examination, digital rectal exam is done carefully. The degree of healing will be reported as none, partial or complete.

Time frame
At 1 week from that start date of the study

Secondary outcomes

1

Change in Pain Score

Pain is evaluated through the Numerical Rating Scale, range 0-10 where 0 = no pain and 10 = worst pain imaginable

Time frame
At 6 and 10 weeks from the start date of the study
2

Wound Healing

Wound healing is assessed through physical examination: digital rectal examination is not done in case of painful anal fissure. Assessment for wound healing will be performed by the treating physician of the patient. The patient will be asked to strain to make the anal fissure more visible. If it is difficult to see on physical examination, digital rectal exam is done carefully.

Time frame
At 6 and 10 weeks from the start date of the study
3

Defecation Strain Score

Level of strain during defecation is graded on a four-point scale: serious strain was scored as 3, moderate strain as 2, mild strain as 1, and defecation without strain as 0

Time frame
At 1 week, 6 weeks, and 10 weeks from that start date of the study
4

Global Impression of Improvement

The patient's global impression of improvement will be measured on a 7-point Likert scale where 1 = very much better, 2 = much better, 3 = a little better, 4 = no change, 5 = a little worse, 6 = much worse, and 7 = very much worse.

Time frame
At 1 week, 6 weeks, and 10 weeks from that start date of the study

Other outcomes

1

Incidence of Treatment-Related Adverse Events

Incidence of Headache, Itching, Dizziness, Hypersensitivity reactions or Critical Change in Vital Signs.

Time frame
At 1 week, 6 weeks, and 10 weeks from that start date of the study

Sponsors and contacts

Click on the lead sponsor to view all of their trials.